Live Cell Imaging Market Outlook 2018-2022

  • ID: 4536702
  • Report
  • Region: Global
  • 110 Pages
  • RNCOS E-Services Private Limited
1 of 4

FEATURED COMPANIES

  • Becton Dickenson & Co.
  • Carl Zeiss GmbH
  • Danaher Corporation
  • GE Healthcare
  • Lonza
  • Merck KGaA
  • MORE

Live Cell Imaging is defined as the study of living cells using high content screening or analysis systems and imaging systems such as microscopes, cell analyzers, etc. These technologies are used in number of investigations in order to provide critical insights into the fundamental nature of tissue and cellular function.
 
The new report “Live Cell Imaging Market Outlook 2022”, includes a comprehensive analysis of the current and future outlooks of the Live Cell Imaging industry. The live cell imaging market is expected to reach US$ 7 Billion by 2022.
 
The report presents an in-depth analysis of several techniques used in imaging of live cells; as well as the segmentation of market by products, applications, technology and geography. Based on product types, the market has been segmented into equipments, consumables and softwares. Equipment market accounted for the largest share in 2017. According to technologies used in live cell imaging, the market has been divided into FRET, FISH, and other major techniques.
 
Similarly, geographical regions include North America, Europe, Asia Pacific and Rest of the World. North America is the largest market for live cell imaging due to high number of cell biology researches conducted in the region. Live cell imaging is widely entering into a number of fields such as cell biology, developmental biology, drug discovery, stem cell biology, neurobiology and electrophysiology. It is emerging as a powerful tool for providing critical insights into cell function, including dynamic processes in living cells with nano-scale resolution in real time. Recent advances in microscopy techniques such as fluorescence light microscopy, including super resolution, photo activation, etc. and confocal microscopy are moving live cell imaging for a number of applications.
 
The last section of the report discusses about the prominent players in global live cell imaging market. A brief business overview and financial information about each of these players has been provided along with their product portfolios. The recent development and strength weakness analysis of every player has also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global live cell imaging market.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Becton Dickenson & Co.
  • Carl Zeiss GmbH
  • Danaher Corporation
  • GE Healthcare
  • Lonza
  • Merck KGaA
  • MORE

1. Analyst View

2. Research Methodology

3. Live Cell Imaging - An Introduction

4. Global Live Cell Imaging Market Overview

5. Market Dynamics
5.1 Drivers
5.1.1 Rising Incidences of Chronic Diseases
5.1.2 Surging Demand for High-Content Screening Techniques
5.1.3 Increasing Funding Support by Public and Private Sector
5.1.4 Availability of Long-term Live Cell Imaging Platform
5.1.5 Live Cell Imaging Instruments Accelerating Drug Discovery
5.2 Challenges
5.2.1 Maintaining Live Cells on Microscope Stage
5.2.2 Mimicking the In Vivo Microenvironment
5.2.3 Lack of Awareness
5.3 Opportunities
5.3.1 Adoption of High Content Screening Systems for Primary Screening
5.3.2 Application of In Vivo Live Cell Imaging Techniques

6. Global Live Cell Imaging Market By Product
6.1 Equipment
6.2 Consumables
6.3 Software

7. Global Live Cell Imaging Market by Application
7.1 Cell Biology
7.2 Developmental Biology
7.3 Stem Cell Biology
7.4 Drug Discovery
7.5 Other Applications

8. Global Live Cell Imaging Market By Technology
8.1 Fluorescent Resonance Energy Transfer (FRET)
8.2 High Content Analysis (HCA)
8.3 Fluorescence In Situ Hybridization (FISH)
8.4 Other Technologies

9. Global Live Cell Imaging Market By Geography
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Rest of the World

10. Trends & Developments
10.1 Fluorescent Probes Enriching Live Cell Imaging
10.2 Introduction of LiveCyte Kinetic Cytometer for Label-free, Quantitative Phase Imaging
10.3 Live Cell Imaging Revealing Intracellular Interactions
10.4 Introduction of Single Plane Illumination Microscopy Advancing Live Cell Imaging

11. Mergers & Other Collaborations

12. Company Profiles
12.1 Carl Zeiss GmbH
12.2 Becton Dickenson & Co.
12.3 Olympus Corporation
12.4 ThermoFisher Scientific Inc.
12.5 Merck KGaA
12.6 PerkinElmer, Inc.
12.7 Nikon Instruments Inc.
12.8 GE Healthcare
12.9 Lonza
12.10 Danaher Corporation

List of Tables:
Table 5-1: Global - Cancer Mortality Cases (Million), 2015 & 2025
Table 5-2: Funds Announced for Live Cell Imaging Research (2013-2015)
Table 9-1: North America - Elderly Population (Million), 2015 & 2030
Table 9-2: North America - Cancer Incidences (Million), 2015 & 2025
Table 9-3: Europe - Elderly Population (Million), 2015 & 2030
Table 9-4: Europe - Cancer Incidences (Million), 2015 & 2025
Table 9-5: Asia Pacific - Elderly Population (Million), 2015 & 2030
Table 9-6: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
Table 9-7: Latin America - Elderly Population (Million), 2015 & 2030
Table 9-8: Latin America - Cancer Incidences (Million), 2015 & 2025
Table 9-9: Africa - Elderly Population (Million), 2015 & 2030
Table 9-10: Africa - Cancer Incidences (Million), 2015 & 2025
Table 12-1: Carl Zeiss GmBH - Key Financials (Million US$), FY 2015-FY 2017
Table 12-2: Becton Dickenson & Co. - Key Financials(Million US$), 2015-2017
Table 12-3: Olympus Corporation - Key Financials (Million US$), 2015-2017
Table 12-4: ThermoFisher Scientific Inc.- Key Financials (Million US$), 2015-2017
Table 12-5: Merck KGaA - Key Financials (Million US$), 2015 - 2017
Table 12-6: PerkinElmer Inc. - Key Financials (Million US$), 2015-2017
Table 12-7: Nikon Corporation. - Key Financials (Million US$), 2015-2017
Table 12-8:GE Healthcare - Key Financials (Million US$), 2015-2017
Table 12-9: Lonza - Key Financials (Million US$), 2015-2017
Table 12-10: Danaher Corporation - Key Financials (Million US$), 2015-2017

List of Figures:
Figure 4-1: Global - Live Cell Imaging Market (Billion US$), 2016-2022
Figure 6-1: Global - Live Cell Imaging Market by Products (%), 2017
Figure 6-2: Global - Live Cell Imaging Equipment Market (Billion US$), 2016 & 2022
Figure 6-3: Global - Live Cell Imaging Consumables Market (Billion US$), 2016 & 2022
Figure 6-4: Global - Live Cell Imaging Consumables Market by Type(%), 2017
Figure 6-5: Global - Live Cell Imaging Software Market (Billion US$), 2016 & 2022
Figure 7-1: Global - Live Cell Imaging Market by Applications (%), 2017
Figure 7-2: Global - Live Cell Imaging Market for Cell Biology (Billion US$), 2016 & 2022
Figure 7-3: Global - Live Cell Imaging Market for Developmental Biology (Billion US$), 2016 & 2022
Figure 7-4: Global - Live Cell Imaging Market for Stem Cell Biology (Billion US$), 2016 & 2022
Figure 7-5: Global - Live Cell Imaging Market for Drug Discovery (Billion US$), 2016 & 2022
Figure 7-6: Global - Live Cell Imaging Market for Other Applications (Billion US$), 2016 & 2022
Figure 8-1: Global - Live Cell Imaging Market by Technology (%), 2017
Figure 8-2: Global - Live Cell Imaging Market for Fluorescent Resonance Energy Transfer (Billion US$), 2016 & 2022
Figure 8-3: Global - Live Cell Imaging Market for High Content Analysis (Billion US$), 2016 & 2022
Figure 8-4: Global - Live Cell Imaging Market for Fluorescence In Situ Hybridization (Billion US$), 2016 & 2022
Figure 8-5: Global - Live Cell Imaging Market for Other Technologies (Billion US$), 2016 & 2022
Figure 9-1: Global - Live Cell Imaging Market by Geography (%), 2017
Figure 9-2: North America - Live Cell Imaging Market (Billion US$), 2016 & 2022
Figure 9-3: Europe - Live Cell Imaging Market (Billion US$), 2016 & 2022
Figure 9-4: Asia Pacific - Live Cell Imaging Market (Billion US$), 2016 & 2022
Figure 9-5: Rest of the World - Live Cell Imaging Market (Billion US$), 2016 & 2022
Figure 12-1: Carl Zeiss GmBH - Revenue Breakup by Business Segments (%), FY 2017
Figure 12-2: Carl Zeiss GmBH - Revenue Breakup by Geography (%), FY 2017
Figure 12-3: Becton Dickenson & Co. - Revenue Breakup by Business Segments (%), 2017
Figure 12-4: Becton Dickenson & Co. - Revenue Breakup by Geography (%), 2017
Figure 12-5: Olympus Corporation - Revenue Breakup by Business Segments (%), 2017
Figure 12-6: Olympus Corporation - Revenue Breakup by Geography (%), 2017
Figure 12-7: Olympus Corporation - Revenue Breakup of Scientific Solutions Business by Geography (%), 2017
Figure 12-8: Thermo Fisher Scientific Inc. - Revenue Breakup by Business Segments (%), 2017
Figure 12-9: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2017
Figure 12-10: Merck KGaA - Breakup of Net Sales By Business Segments (%), 2017
Figure 12-11: Merck KGaA - Breakup of Net Sales By Geography (%), 2017
Figure 12-12: PerkinElmer Inc. - Revenue Breakup by Business Segments (%), 2017
Figure 12-13: PerkinElmer Inc. - Revenue Breakup by Geography (%), 2017
Figure 12-14: Nikon Corporation - Breakup of Net Sales by Business Segments (%), 2017
Figure 12-15: Nikon Corporation - Breakup of Net Sales by Geography (%), 2017
Figure 12-16: GE Healthcare - Revenue Breakup by Business Segments (%), 2017
Figure 12-17: GE Healthcare - Breakup of Revenue by Geographies (%), 2017
Figure 12-18: Lonza - Breakup of Sales by Business Segments (%), 2017
Figure 12-19: Danaher Corporation - Breakup of Sales by Business Segments (%), 2017
Figure 12-20: Danaher Corporation - Breakup of Sales by Geography (%), 2017

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Carl Zeiss GmbH
  • Becton Dickenson & Co.
  • Olympus Corporation
  • ThermoFisher Scientific Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Nikon Instruments Inc.
  • GE Healthcare
  • Lonza
  • Danaher Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll